Technology-enabled Collaborative Care for Diabetes Management During COVID-19

Technology-enabled Collaborative Care for Diabetes (TECC-Diabetes) Management During COVID: A Feasibility Study

The overall goal of this research program is to evaluate the effectiveness of a Technology-Enabled Collaborative Care program. In this study, we examine the feasibility of such a program, called the Technology-Enabled Collaborative Care (TECC) for type 2 diabetes designed to support patients with diabetes and mental health concerns during COVID-19.

There is growing concern regarding the impact of COVID-19 and social isolation on mental health and wellbeing, particularly adults living with type 2 diabetes (T2DM), who are at greater risk for mental health issues than the general population. Self-management education and support for healthy eating, physical activity, glucose monitoring, medication adherence and problem solving are vital components of diabetes care. Due to social distancing and limited care and resources, that are likely to persist in the post pandemic phase other innovative service models should be developed and adopted to improve service delivery. The overall goal of this research program is to evaluate the effectiveness of a Technology-Enabled Collaborative Care program. In this study, we examine the feasibility of such a program, called the Technology-Enabled Collaborative Care (TECC) for T2DM designed to support patients with diabetes and mental health concerns during COVID-19.

Inclusion Criteria:

• Age: 18 years and older
• Clinician diagnosis of Type 2 diabetes for at least one year
• A1C level of 7.5% or higher within the last 6 months (benchmark is 7%)
• Access to telephone or internet through computer or mobile
• Experiencing some distress, score of ** on Perceived Stress Scale

Exclusion Criteria:

• Unable to provide consent
• Unable to understand English
• Pregnant or planning to get pregnant during the course of the study